Macquarie Group
SILK

Macquarie Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Macquarie Group’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-81,563
Closed -$1.22M – 1699
2023
Q3 		$1.22M Buy
81,563
+1,591
+2% +$33.1K ﹤0.01% 1295
2023
Q2 		$2.6M Buy
79,972
+22,006
+38% +$804K ﹤0.01% 1099
2023
Q1 		$2.27M Sell
57,966
-64,115
-53% -$3.14M ﹤0.01% 1124
2022
Q4 		$6.45M Buy
122,081
+51,089
+72% +$2.49M 0.01% 929
2022
Q3 		$3.22M Sell
70,992
-28,510
-29% -$1.23M ﹤0.01% 1094
2022
Q2 		$3.62M Sell
99,502
-295
-0.3% -$10.7K ﹤0.01% 1119
2022
Q1 		$4.12K Buy
99,797
+10,506
+12% +$370K ﹤0.01% 1166
2021
Q4 		$3.81M Buy
89,291
+16,557
+23% +$828K ﹤0.01% 1198
2021
Q3 		$4M Sell
72,734
-1,500
-2% -$78.5K ﹤0.01% 1171
2021
Q2 		$3.55M Buy
74,234
+12,531
+20% +$638K ﹤0.01% 1234
2021
Q1 		$3.13M Buy
61,703
+17,673
+40% +$982K ﹤0.01% 1045
2020
Q4 		$2.77M Buy
44,030
+3,463
+9% +$215K ﹤0.01% 1009
2020
Q3 		$2.73M Sell
40,567
-54,414
-57% -$2.97M ﹤0.01% 961
2020
Q2 		$3.98M Buy
94,981
+35,458
+60% +$1.36M 0.01% 845
2020
Q1 		$1.87M Buy
59,523
+13,409
+29% +$537K ﹤0.01% 928
2019
Q4 		$1.86M Buy
+46,114
New +$1.61M ﹤0.01% 1061

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Macquarie Group's SILK Position: Q4 2023 in Review

Macquarie Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 81,563 shares — an estimated $1.22M sold.

Macquarie Group first reported a position in SILK in Q4 2019 and held it in 16 quarters. The position peaked at $6.45M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Macquarie Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Macquarie Group sold 81,563 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $1.22M.
  • Macquarie Group first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Macquarie Group's Silk Road Medical, Inc. Common Stock position peaked at $6.45M in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Macquarie Group's 13F filing for Q4 2023, filed 14 Feb 2024.